Page last updated: 2024-08-23

alovudine and Carcinoma, Epidermoid

alovudine has been researched along with Carcinoma, Epidermoid in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (32.00)29.6817
2010's17 (68.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buatti, JM; Menda, Y1
Arens, AI; Bussink, J; Grégoire, V; Grootjans, W; Hatt, M; Hoeben, BA; Kaanders, JH; Lee, JA; Oyen, WJ; Troost, EG; Visser, EP; Visvikis, D1
Bussink, J; Hoeben, BA; Kaanders, JH; Oyen, WJ; Troost, EG; van Herpen, CM1
Bradshaw, TJ; Forrest, LJ; Jallow, N; Jeraj, R; Yip, S1
Chalkidou, A; Fenwick, JD; Landau, DB; Liu, D; Marsden, PK1
Bai, GH; Cabrera, AR; Lee, J; Li, YH; Liu, J; Sun, XD; Yang, J; Yu, JM; Yue, JB1
An, H; Chen, H; Li, Y; Lin, Q; Sun, L; Wu, H; Zhao, L1
Fukumura, T; Hoshikawa, H; Kishino, T; Mori, N; Mori, T; Nishiyama, Y; Samukawa, Y; Yamamoto, Y2
Carlson, ER; Heidel, RE; Schaefferkoetter, JD1
Cao, J; Li, D; Ma, C; Yin, Y1
Fukumoto, D; Harada, N; Kakiuchi, T; Kamijo, A; Kawaguchi, AT; Murayama, C; Tsukada, H1
Choi, SJ; Im, KC; Kim, JS; Kim, SJ; Kim, SW; Kim, SY; Lee, JS; Lee, SJ; Moon, DH; Oh, SJ; Park, SA; Ryu, JS; Yun, SC1
Fu, Z; Han, D; He, W; Huo, Z; Kong, L; Liu, X; Lu, J; Mu, D; Sun, X; Yin, Y; Yu, J; Yu, Y; Zhang, B; Zhang, G; Zhao, S; Zhong, X1
Cabrera, AR; Chen, L; Han, A; Han, D; Li, Y; Ma, L; Ma, Y; Mu, D; Sun, X; Teng, X; Yu, J; Yue, J; Zhao, S; Zhao, X; Zheng, F; Zheng, J1
Bussink, J; Kaanders, JH; Merkx, MA; Oyen, WJ; Peeters, WJ; Slootweg, PJ; Troost, EG; van der Kogel, AJ1
Fu, Z; Han, D; Mu, D; Xu, G; Yang, W; Yu, J; Zhang, B; Zhao, S; Zhong, X1
Hoshikawa, H; Kishino, T; Mori, N; Nishiyama, Y; Yamamoto, Y1
Bussink, J; Hoeben, BA; Kaanders, JH; Oyen, WJ; Span, PN; Troost, EG; van Herpen, CM1
Bares, R; Bartusek, G; Dittmann, H; Dohmen, BM; Kehlbach, R; Pritzkow, M; Sarbia, M1
Cobben, DC; Elsinga, PH; Hoekstra, HJ; Jager, PL; Maas, B; Suurmeijer, AJ; Vaalburg, W; van der Laan, BF1
Fukumoto, D; Harada, N; Hirano, T; Kakiuchi, T; Kohno, E; Sakahara, H; Sato, K; Sugiyama, M; Tsukada, H1
Barrio, J; Czernin, J; Halpern, BS; Mellinghoff, IK; Phelps, ME; Rozengurt, N; Safaei, A; Satyamurthy, N; Sawyers, CL; Silverman, DH; Stout, D; Tran, C; Waldherr, C; Weber, WA1
Cheon, GJ; Cho, KJ; Im, KC; Kim, SY; Lee, H; Lee, SW; Moon, DH; Oh, SJ; Ryu, JS; Yang, YJ1
Atkinson, DM; Carlson, BL; Clarke, MJ; Jacobson, MS; Kemp, BJ; Lowe, VJ; Mladek, AC; Sarkaria, JN; Trump, DP1

Trials

4 trial(s) available for alovudine and Carcinoma, Epidermoid

ArticleYear
Comparison of characteristics of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET during staging of esophageal squamous cell carcinoma.
    Nuclear medicine communications, 2015, Volume: 36, Issue:12

    Topics: Adult; Aged; Carcinoma, Squamous Cell; Dideoxynucleosides; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography

2015
Measuring tumor cell proliferation with 18F-FLT PET during radiotherapy of esophageal squamous cell carcinoma: a pilot clinical study.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2010, Volume: 51, Issue:4

    Topics: Aged; Aged, 80 and over; Bone Marrow Cells; Carcinoma, Squamous Cell; Cell Proliferation; Diagnosis, Differential; Dideoxynucleosides; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lymphatic Metastasis; Male; Middle Aged; Neoplasm, Residual; Pilot Projects; Positron-Emission Tomography; Tomography, X-Ray Computed

2010
Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
    Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2012, Volume: 25, Issue:5

    Topics: Aged; Carcinoma, Squamous Cell; Dideoxynucleosides; Esophageal Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed

2012
18F-FLT PET during radiotherapy or chemoradiotherapy in head and neck squamous cell carcinoma is an early predictor of outcome.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:4

    Topics: Adult; Aged; Biological Transport; Carcinoma, Squamous Cell; Dideoxynucleosides; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Time Factors; Treatment Outcome

2013

Other Studies

21 other study(ies) available for alovudine and Carcinoma, Epidermoid

ArticleYear
PET imaging during radiotherapy of head and neck cancer.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:4

    Topics: Carcinoma, Squamous Cell; Dideoxynucleosides; Female; Head and Neck Neoplasms; Humans; Male; Positron-Emission Tomography

2013
Semiautomatic methods for segmentation of the proliferative tumour volume on sequential FLT PET/CT images in head and neck carcinomas and their relation to clinical outcome.
    European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:5

    Topics: Adult; Aged; Carcinoma, Squamous Cell; Dideoxynucleosides; Female; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden

2014
18F-FLT PET changes during radiotherapy combined with cetuximab in head and neck squamous cell carcinoma patients.
    Nuklearmedizin. Nuclear medicine, 2014, Volume: 53, Issue:2

    Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Dideoxynucleosides; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Reproducibility of Results; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome

2014
Spatiotemporal stability of Cu-ATSM and FLT positron emission tomography distributions during radiation therapy.
    International journal of radiation oncology, biology, physics, 2014, Jun-01, Volume: 89, Issue:2

    Topics: Adenocarcinoma; Animals; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Proliferation; Chondrosarcoma; Coordination Complexes; Dideoxynucleosides; Dog Diseases; Dogs; Dose Fractionation, Radiation; Multimodal Imaging; Nose Neoplasms; Organometallic Compounds; Osteosarcoma; Paranasal Sinus Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Thiosemicarbazones; Tomography, X-Ray Computed

2014
18F-FLT uptake kinetics in head and neck squamous cell carcinoma: a PET imaging study.
    Medical physics, 2014, Volume: 41, Issue:4

    Topics: Biological Transport; Carcinoma, Squamous Cell; Cell Proliferation; Dideoxynucleosides; Head and Neck Neoplasms; Humans; Kinetics; Models, Biological; Positron-Emission Tomography

2014
Histopathologic validation of 3'-deoxy-3'-18F-fluorothymidine PET for detecting tumor repopulation during fractionated radiotherapy of human FaDu squamous cell carcinoma in nude mice.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2014, Volume: 111, Issue:3

    Topics: Animals; Carcinoma, Squamous Cell; Cell Growth Processes; Cell Line, Tumor; Dideoxynucleosides; Dose Fractionation, Radiation; Female; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals; Random Allocation; Squamous Cell Carcinoma of Head and Neck; Xenograft Model Antitumor Assays

2014
3'-deoxy-3'-[¹⁸F]-fluorothymidine PET/CT in early determination of prognosis in patients with esophageal squamous cell cancer: comparison with [¹⁸F]-FDG PET/CT.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2015, Volume: 191, Issue:2

    Topics: Adult; Aged; Carcinoma, Squamous Cell; Dideoxynucleosides; Disease-Free Survival; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; ROC Curve; Tomography, X-Ray Computed; Young Adult

2015
Predictive value of SUV-based parameters derived from pre-treatment (18)F-FLT PET/CT for short-term outcome with head and neck cancers.
    Annals of nuclear medicine, 2014, Volume: 28, Issue:10

    Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Dideoxynucleosides; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Tumor Burden

2014
Prognostic value comparison between (18)F-FLT PET/CT and (18)F-FDG PET/CT volume-based metabolic parameters in patients with head and neck cancer.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden

2015
Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2015, Volume: 73, Issue:7

    Topics: Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Squamous Cell; Cell Proliferation; Cohort Studies; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neck Dissection; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed

2015
Evaluation of D-18F-FMT, 18F-FDG, L-11C-MET, and 18F-FLT for monitoring the response of tumors to radiotherapy in mice.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2009, Volume: 50, Issue:2

    Topics: Animals; Carbon Radioisotopes; Carcinoma, Squamous Cell; Cell Line, Tumor; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Methionine; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Positron-Emission Tomography; Tyrosine

2009
Reproducibility of the kinetic analysis of 3'-deoxy-3'-[(18)F]fluorothymidine positron emission tomography in mouse tumor models.
    Nuclear medicine and biology, 2009, Volume: 36, Issue:7

    Topics: Animals; Carcinoma, Lewis Lung; Carcinoma, Squamous Cell; Cell Line, Tumor; Dideoxynucleosides; Disease Models, Animal; Humans; Kinetics; Male; Mice; Observer Variation; Positron-Emission Tomography; Reproducibility of Results

2009
Comparison of (18)F-fluorothymidine and (18)F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus.
    International journal of radiation oncology, biology, physics, 2010, Mar-15, Volume: 76, Issue:4

    Topics: Carcinoma, Squamous Cell; Dideoxynucleosides; Dose Fractionation, Radiation; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Heart; Humans; Lung; Lymph Node Excision; Male; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Spinal Cord; Tomography, X-Ray Computed; Tumor Burden

2010
Histopathologic validation of 3'-deoxy-3'-18F-fluorothymidine PET in squamous cell carcinoma of the oral cavity.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2010, Volume: 51, Issue:5

    Topics: Biomarkers; Carcinoma, Squamous Cell; Dideoxynucleosides; Female; Humans; Idoxuridine; Image Processing, Computer-Assisted; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Mouth Neoplasms; Phosphorylation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Thymidine Kinase; Tomography, Emission-Computed

2010
Usefulness of 3'-deoxy-3'-18F-fluorothymidine PET for predicting early response to chemoradiotherapy in head and neck cancer.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Squamous Cell; Chemoradiotherapy; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Time Factors; Treatment Outcome

2012
Early changes in [18F]FLT uptake after chemotherapy: an experimental study.
    European journal of nuclear medicine and molecular imaging, 2002, Volume: 29, Issue:11

    Topics: Antineoplastic Agents; Artifacts; Carcinoma, Squamous Cell; Cell Survival; Cisplatin; Deoxycytidine; Dideoxynucleosides; Dose-Response Relationship, Drug; Esophageal Neoplasms; Fluorodeoxyglucose F18; Fluorouracil; Gemcitabine; Humans; Methotrexate; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tumor Cells, Cultured

2002
18F-FLT PET for visualization of laryngeal cancer: comparison with 18F-FDG PET.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:2

    Topics: Aged; Biopsy; Carcinoma, Squamous Cell; Dideoxynucleosides; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Larynx; Male; Neoplasm Recurrence, Local; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed

2004
Evaluation of 3'-deoxy-3'-18F-fluorothymidine for monitoring tumor response to radiotherapy and photodynamic therapy in mice.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:10

    Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Dideoxynucleosides; Female; HeLa Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Nude; Organ Specificity; Photochemotherapy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy; Tissue Distribution; Treatment Outcome

2004
Monitoring antiproliferative responses to kinase inhibitor therapy in mice with 3'-deoxy-3'-18F-fluorothymidine PET.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2005, Volume: 46, Issue:1

    Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Mice; Mice, SCID; Neoplasm Invasiveness; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Radiopharmaceuticals; Treatment Outcome

2005
Use of 3'-deoxy-3'-[18F]fluorothymidine PET to monitor early responses to radiation therapy in murine SCCVII tumors.
    European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:4

    Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Male; Mice; Mice, Inbred C3H; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome

2006
Using fluorodeoxythymidine to monitor anti-EGFR inhibitor therapy in squamous cell carcinoma xenografts.
    Head & neck, 2008, Volume: 30, Issue:6

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Squamous Cell; Cetuximab; Dideoxynucleosides; Disease Models, Animal; ErbB Receptors; Erlotinib Hydrochloride; Female; Fluorine Radioisotopes; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Positron-Emission Tomography; Protein Kinase Inhibitors; Quinazolines

2008